FDA Could Green-Light COVID-19 Vaccines Before Clinical Trials Completed
MONDAY, Aug. 31, 2020 -- Emergency use authorization (EUA) or approval for a COVID-19 vaccine before phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administration, according to the agency's commissioner, Stephen Hahn, M.D.
"It is up to the sponsor [vaccine developer] to apply for authorization or approval, and we make an adjudication of their application," he told the Financial Times, CNN reported. "If they do that before the end of phase 3, we may find that appropriate. We may find that inappropriate, we will make a determination." An EUA is not the same as full-fledged approval, Hahn noted. "Our emergency use authorization is not the same as a full approval," he said. "The legal, medical, and scientific standard for that is that the benefit outweighs the risk in a public health emergency."
Two vaccines are currently in phase 3 trials in the United States and two more are expected to begin phase 3 trials by mid-September, CNN reported.
Data, not politics, would guide any FDA decision on vaccines, according to Hahn. "We have a convergence of the COVID-19 pandemic with the political season, and we're just going to have to get through that and stick to our core principles," he said, CNN reported. "This is going to be a science, medicine, data decision. This is not going to be a political decision."
© 2021 HealthDay. All rights reserved.
Posted August 2020
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 26 to 30, 2021. This roundup...
FRIDAY, July 30, 2021 -- Israelis who are over the age of 60 and fully vaccinated against COVID-19 will be offered booster shots, Prime Minister Naftali Bennett said...
FRIDAY, July 30 2021 -- School closures in 2020 during the COVID-19 pandemic negatively affected the mental health of students, according to a U.S. study published online July 20...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.